Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype.

Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype.

<h4>Background</h4>Vitamin K-antagonists (VKA) are treatment of choice and standard care for patients with venous thrombosis and thromboembolic risk. In experimental animal models as well as humans, VKA have been shown to promote medial elastocalcinosis. As vascular calcification is cons...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Leon J Schurgers, Ivo A Joosen, Eduard M Laufer, Martijn L L Chatrou, Marjolein Herfs, Mark H M Winkens, Ralf Westenfeld, Verena Veulemans, Thilo Krueger, Catherine M Shanahan, Willi Jahnen-Dechent, Erik Biessen, Jagat Narula, Cees Vermeer, Leonard Hofstra, Chris P Reutelingsperger
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2012
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/073113b23a7543c09f9b7724adf5511a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/073113b23a7543c09f9b7724adf5511a

Documents similaires